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Background: Sepsis with brain dysfunction has contributed to an increase risk of morbidity and mortality. In its
pathophysiology, both autophagy and nuclear factor κB (NF-κB) have been suggested to play important roles.
Based on the fact that crosstalk between autophagy and NF-κB, two stress-response signaling pathways, has been
detected in other pathophysiological processes, this study was undertaken to explore the process of autophagy in
the hippocampus of septic rats and the role NF-κB plays in the regulation of autophagy during the process.
Methods: Cecal ligation and puncture (CLP) or a sham operation was conducted on male Wistar rats. Pyrrolidine
dithiocarbamate (PDTC), an inhibitor of the NF-κB signaling pathway, or a vehicle control, was used to treat with
the rats 2 h before the CLP operation. Hematoxylin-eosin staining and biological signal recording was used to measure
the morphological and physiological signs of hippocampal dysfunction. An electron microscope was used to observe
autophagosome formation and lysosome activation in the hippocampus after CLP. Western blotting and immune
histochemistry were used to detect the hippocampus levels of NF-κB and essential proteins involved in formation of
the autophagosome (microtubule-associated protein light chain 3 (LC3), Beclin1, Lamp-1, and Rab7).
Results: Compared with sham-operated rats, the CLP rats showed decreasing mean arterial pressure (MAP), increasing
heart rate (HR), and pathological histological changes. CLP rats exhibited not only increased vacuolization through
electron micrographs but also increased LC3-II, decreased Beclin1, LAMP-1, and Rab7 through the immunofluorescence
and Western blot. However, PDTC + CLP rats revealed that inhibition of the NF-κB signal axis by PDTC increased the
levels of LC3-II, Beclin1, LAMP-1, and Rab7 and improved physiological function including blood pressure and heart
rate.
Conclusions: The autophagy process during the hippocampus of CLP rats might be blocked by the activation of
NF-κB signaling pathway. Inhibition of NF-κB signaling pathway could enhance the completion of autophagy
with a neuroprotective function in septic brains.
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Septic brain damage, characterized by diffuse brain dys-
function which occurs following infection and without
infection of the CNS, is becoming an emerging problem
in pediatric intensive care units (PICU) [1]. More than
50 % of sepsis patients are diagnosed with varying de-
grees of brain damage [2].* Correspondence: hxlixihong@126.com
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ing from sepsis and their underlying processes remain
poorly understood, several plausible mechanisms have
been proposed, including involvement of inflammatory
cytokines [3], altered cerebral microcirculation [4], al-
tered cerebral metabolism [5], altered neurotransmission
[6], blood–brain barrier compromise [7], and micro-
scopic brain injury [8, 9]. It could be most likely that
septic brain dysfunction is induced by a combination of
these processes, which may act in concert or independ-
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important role in the pathophysiology of sepsis [10–
12]. Autophagy is a conserved process by which long-
lived proteins and damaged organelles are delivered to
the lysosome for degradation and recycling [13]. Numer-
ous studies have revealed that autophagy participates in
processes such as cell metabolism, protein secretion, and
cell-mediated immune responses [14–17]. Moreover,
autophagy has been noted for its roles in cellular homeo-
stasis, development, cell survival, immunity, as well as
cancer. In addition, recent evidences imply that
autophagy plays a crucial role in numerous neurode-
generative diseases including Parkinson’s disease, Alz-
heimer’s disease, and Huntington’s disease [18, 19]. It
has been acknowledged that inflammation contributes
to the progression of these diseases. Thus, crosstalk
between inflammation and autophagy has attracted
much attention in recent years. However, the relation-
ship between autophagy and brain disorder occurring
with sepsis remains unclear [20, 21].
The nuclear factor κB (NF-κB) family of Rel-related
transcription factors, existing in almost all cells, is widely
involved in functions such as immunity, inflammation,
and stress response. In unstimulated cells, NF-κB, se-
questered in the cytoplasm by binding to inhibitory κB
(IκB) proteins, can be activated by various stimuli, espe-
cially by tumor-necrosis-factor alpha (TNF-α), interleu-
kin (IL), and bacterial endotoxins. Once cells activate,
the IκB proteins degrade. NF-κB translocates to the
nucleus and binds to its DNA-binding sites, which
enhances transcriptional activity of the respective genes
involved in the control of different cellular responses
[22, 23]. Recent studies have discovered that autophagy
is required for the activation of NF-κB [22]. NF-κB has
been found to negatively regulate the autophagy in spe-
cific cell type in vitro [23], which indicates an intimate
crosstalk between the two signaling pathways.
In the present study, we set out to investigate whether
autophagy is involved in the physiopathology of brain
disorder occurring with sepsis and whether NF-κB sig-
naling pathways modulate the autophagic capacity of
hippocampal cells during sepsis by using pretreatment




Thirty-day-old male Wistar rats (100 to 120 g) were pur-
chased from Sichuan Jianyang Dashuo Animal Science
and Technology Co., Ltd. All rats were housed with free
access to food and water in a 22–25 °C, 55–58 % relative
humidity environment on a 12-h light/dark cycle. Every
effort was made to minimize the number and suffering
of animals used.In the experiments, Wistar rats were randomly divided
into four groups: cecal ligation and puncture group
(CLP), sham-operated group, PDTC-treated group
(PDTC + CLP), and vehicle-treated group (Veh + CLP).
Each group was randomly divided into 3-, 6-, 12-, 24-,
and 48-h groups. For the CLP group, sepsis was induced
by CLP, as described previously by Rittirsch et al. [24].
Firstly, anesthesia was conducted with 10 % (w/v) chloral
hydrate (1 ml/300 mg, i.p.), followed by a 2-cm midline
abdominal incision. Secondly, the cecum was exteriorized
and ligated immediately distal to the ileocecal valve.
Thirdly, the cecum was punctured twice with an 18-gauge
hollow-bore needle. Finally, the abdominal wall was closed
in two layers. For the sham-operated group, rats were
treated identically, except that the cecum was neither li-
gated nor punctured. The PDTC-treated group rats were
injected intraperitoneally with PDTC (100 mg/kg, BioVi-
sion, USA) 2 h before the operation [25]. For the vehicle-
treated group, mice received the same volume of vehicle
(DMSO, 6.7 ml/kg, Solarbio, USA) intraperitoneally. Each
animal received a subcutaneous injection of 5 ml 0.9 %
(w/v) saline to compensate for the blood volume lost dur-
ing the surgery. All surgical procedures were performed in
an aseptic manner and were approved by the Research
Animal Care Committee of Sichuan University.
Physiological examination
Anesthesia was completed with 10 % (w/v) chloral hy-
drate by intraperitoneal injection. An indwelling tube
was placed in the femoral artery to provide a venous
channel for connecting the iWorx biological signal re-
corder, which was used to monitor the blood pressure
and heart rate continually.
Histological examination
Rats were deeply anesthetized by an intraperitoneal in-
jection of 10 % (w/v) chloral hydrate then transcardially
perfused with 200 ml of 5 mM sodium phosphate-
buffered 0.9 % (w/v) saline (PBS; pH 7.3), followed by
200 ml of 4 % (w/v) paraformaldehyde in 0.1 M phos-
phate buffer (PB; pH 7.3). After the brains were har-
vested and fixed in 4 % (w/v) paraformaldehyde at 4 °C
for 24–48 h, they were cut in a coronal plane—from the
optic chiasma through to the back (1 cm long) with the
segment of the brain tissue paraffin-embedded. Then,
brain samples were cut (6 mm thick) and routinely
stained with hematoxylin and eosin. Finally, the Leica
inverted optical microscope was used to capture images
(Leica, USA).
Electron microscopy
The tissue samples for electron microscopy were ob-
tained 2 mm posterior to the optic chiasma in a cor-
onal plane (1 mm long) and were then fixed in a buffer
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glutaraldehyde in 0.1 M PBS at 4 °C for 24–36 h. After-
wards, they were post-fixed in 3 % (v/v) glutaraldehyde
and 1 % (w/v) phosphate-buffered osmium tetroxide
and embedded in Epon812. Then, sections were cut at
0.12 μm thickness and stained with 0.2 % (w/v) lead cit-
rate and 1 % (w/v) uranyl acetate, which were subse-
quently observed under an H-600IV transmission
electron microscope (Hitachi, Japan).Western blot analysis
Experimental and control animals were deeply anesthe-
tized by injection of 10 % (w/v) chloral hydrate (1 ml/
300 mg, i.p.) and then rapidly sacrificed at 3, 6, 12, 24,
and 48 h post-operation. The brains were rapidly
dissected out on a bed of ice. The hippocampus was
dissected out from each hemisphere and deposited in
ice-cold lysis buffer (50 mmol/l Tris–HCl pH 7.4,
150 mmol/l NaCl, 10 mg/l NP-40, 0.1 % protease in-
hibitor cocktail (Roche, USA)). Tissue samples were
homogenized on ice with tweezers. Homogenates were
centrifuged at 12,000 g for 30 min at 4 °C. The super-
natant was collected and stored at −80 °C. All samples
were analyzed for protein content with the BCA assay
(Sigma, USA) to ensure equal protein loading. Proteins
were separated by 12 % SDS-PAGE and transferred to
nitrocellulose. For immunoblotting, membranes were
blocked with 5 % (w/v) milk in TBS-T at 4 °C overnight;
incubated with the following primary antibodies: rabbit
anti- microtubule-associated protein light chain poly-
clonal antibody (LC3; 1:2000, Novus, USA), rabbit anti-
Beclin1 polyclonal antibody (1:2000, CellSignaling,
USA), rabbit anti-Rab7 monoclonal antibody (1:1000,
Abcam, USA), rabbit anti-lysosome-associated mem-
brane protein-1 polyclonal antibody (LAMP-1; 1:1000,
Abcam, USA), mouse anti-NF-κB monoclonal antibody
(1:2000, Millipore, USA), and mouse anti-actin mono-
clonal antibody (1:3000, Cell Signaling, USA) in 5 %
(w/v) milk in TBS-T at room temperature for 2 h; and
washed and incubated with a 1:2000 dilution of HRP-
conjugated anti-rabbit or anti-mouse secondary anti-
body (1:3000, ZSGB- BIO, China) in 3–5 % (w/v) milk
in TBS-T for 1 h at room temperature. Bands were vi-
sualized with enhanced chemiluminescence (ECL,
Millipore, USA) by using the gel imaging analysis sys-
tem (Bio-RAD, USA). In addition, Western blot ana-
lysis was performed with a beta-actin antibody (1:3000)
as a loading control. The intensity of each band was
quantitatively determined by Gel-Pro Image Analyzer
Software. The density ratio represented the relative in-
tensity of each band against actin. The intensity of blots
was quantified with densitometry by people who were
blinded to the treatments.Immunofluorescence staining
At the time points of 3, 6, 12, 24, and 48 h after CLP
surgery, the rats were deeply anesthetized by injection of
10 % (w/v) chloral hydrate (1 ml/300 mg, i.p.) and trans-
cardially perfused with 200 ml of 5 mM sodium
phosphate-buffered 0.9 % (w/v) saline (PBS; pH 7.3),
followed by 200 ml of 4 % (w/v) paraformaldehyde in
0.1 M phosphate buffer (PB; pH 7.3). The brains were
harvested and fixed in 4 % (w/v) paraformaldehyde at 4 °
C for 24–48 h. Brain samples were embedded in 4 % (w/
v) agarose and were cut (40 μm thick) with an oscillate
slicer. The sections were washed three times in PBS and
blocked for 1 h at room temperature in PBS containing
2 % (v/v) fetal calf serum and 0.2 % (v/v) Triton X-100.
Primary antibodies rabbit anti-LC3 polyclonal antibody
(1:200, Novus, USA) or mouse anti-NeuN monoclonal
antibody (1:200, Millipore, USA) in PBS containing 1 %
(v/v) fetal calf serum and 0.1 % (v/v) Triton X-100 were
added and incubated at 4 °C overnight. Next, the sec-
tions were washed three times in PBS (10 min each) and
incubated with a mixture of DyLight 488-conjugated
donkey anti-rabbit IgG (1:800, Jackson ImmunoRe-
search, USA) and Cy3-conjugated donkey anti-mouse
IgG (1:800, Jackson ImmunoResearch, USA) for 1 h in
PBS containing 1 % (v/v) fetal calf serum and 0.1 % (v/v)
Triton X-100 at room temperature. Afterwards, the sec-
tions were washed for another three times in PBS
(10 min each). Then, 4,6-diamidino-2-phenylindole
(DAPI, 1:5000, Beyotime, China) nuclear stain was ap-
plied (1 μg/ml in PBS) for 10 min at room temperature.
After staining, all of the sections were mounted onto
glass slides and cover-slipped with antifade mounting
medium (Beyotime, China). Using a confocal laser scan-
ning microscope (Olympus, Japan), the sections were
observed with the appropriate laser beams and filter set-
tings for green-emitting Dylight 488 (excitation peak
493 nm, emission peak 518 nm) or red-emitting Cy3
(excitation peak 550 nm, emission peak 570 nm). The
digital images were captured with FV10-ASW-3.1 soft-
ware (Olympus, Japan).
Statistical analysis
Data are expressed as mean ± SEM and analyzed by one-
way ANOVA followed by the Student-Newman-Keuls
test. All statistical analyses were performed by using the
Statistical Package for Social Sciences (Version 19.0).
P < 0.05 was considered statistically significant.
Results
Vital signs (blood pressure and heart rate) at different
time points
The mean arterial pressure (MAP) was significantly
(P < 0.05) lower in the CLP group than in the sham-
operated group at each time point. The MAP began to
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gradually rose by 48 h (Table 1). Conversely, the HR
was significantly higher (P < 0.05) in the CLP group
than in the sham-operated group at each time point
(Table 1). In the PDTC + CLP groups, the vital signs
were much higher (P < 0.05) than those in both the CLP
groups and the vehicle control groups. It can be concluded
that the MAP level was strikingly higher (P < 0.05) in the
PDTC +CLP groups than in the CLP groups and that the
HR level was notably lower (P < 0.05) in the PDTC +CLP
groups than in the CLP groups (Table 2).Histological examination of brain tissue
In the hippocampus of sham-operated group rats, almost
no tissue alteration was observed at both the macro-
scopic and light microscopic levels (Fig. 1a). CLP-3 h
rats showed slight neuronal edema (Fig. 1b). In CLP-
12 h rats with swollen hippocampal tissue, disordered
arrangement of hippocampus and unclear structure neu-
rons appeared changed in an acute traumatic manner
(Fig. 1c).Characterization of autophagic vacuoles after CLP and
PDTC treatment by electron micrograph
Autophagic vacuoles were observed by transmission
electron microscopy. As shown in Fig. 2a, the hippocam-
pal tissue from sham-operated rats displayed nearly nor-
mal structure and proper organelle distribution. No
alteration of tissue integrity was observed in low magni-
fication images. In Fig. 2b, CLP rats demonstrated au-
tophagic vacuolization. A number of irregularities were
seen sporadically in high-power electron microscopic
images, including a large autophagosome containing
mitochondria and other organelles, herniation of outer
membranes of endoplasmic reticulum into adjacent lyso-
somal structures. Other changes including prominent
matrix granules and crystalline-like inclusion were seen
in selected examples of septic rats. The PDTC-treated
rats showed multiple double or multiple-membrane au-
tophagic vesicles in the cytoplasm, with loss of discern-
able organellar fragments. Autophagosomes assume a
more complex appearance, with redundant whorls of
membrane-derived material. As shown in Fig. 2, there
were many differences among the sham group, the CLP
group, and the PDTC-treated group in the performance
of the rats’ hippocampus, which indicates thatTable 1 Vital signs at specific time points for each group (n = 5)
Sham 3 h 6 h
MAP (mmHg) 96.2 ± 4.49 91.0 ± 2* 81.6 ± 2
HR (beats/min) 317.2 ± 10.08 343.8 ± 12.58* 368.0 ± 2
Values are expressed as means ± SEM
*P < 0.05 vs sham-operated groupintraperitoneal administration of PDTC has an impact
on autophagic vacuolization.LC3 expression was increased in the hippocampal tissue
after CLP surgery
Hippocampal tissues were harvested from rats at the
time points of 3, 6, 12, 24, and 48 h after CLP. LC3-II
significantly increased in CLP rats at 6, 12, 24, and 48 h
after surgery than in sham-operated rats (P < 0.05;
Fig. 3a). The punctate form and distribution of LC3 was
examined to assess the autophagosomes by fluorescence
microscopy. As shown in Fig. 3b, hippocampal cells of
sham-operated animals expressed ubiquitously with dif-
fuse in both the nucleus and cytoplasm of cells for LC3.
Hippocampal cells after CLP appeared like intense
granular LC3 staining predominantly in the cytosol.
There was no notable difference in LC3 protein level be-
tween sham-operated rats at the time points of 3, 6, 12,
24, and 48 h post-surgery.Beclin1, Rab7, and LAMP-1 expression in hippocampal
tissue
Hippocampal tissues were harvested from rats at the
time points of 3, 6, 12, 24, and 48 h after CLP. Though
Beclin1 level increased considerably at 6 h, it declined
from 12 h after CLP compared with that in sham-
operated rats (P < 0.05; Fig. 4a). LAMP-1 level dropped
fast at the time points of 3, 6, 12, 24, and 48 h after CLP
compared with that in sham-operated rats (P < 0.05;
Fig. 4b). Rab7 level decreased at the time points of 12,
24, and 48 h after CLP compared with that in sham-
operated rats (P < 0.05; Fig. 4c). There were few differ-
ences in Beclin1, Rab7, or LAMP-1 protein levels be-
tween sham-operated rats at the time points of 3, 6, 12,
24, and 48 h post-surgery.
NF-κB expression in CLP and PDTC-treated hippo-
campal tissueHippocampal tissues were harvested from
rats at the time points of 3, 6, 12, 24, and 48 h after
CLP. NF-κB increased at 12 and 24 h after CLP com-
pared with that in sham-operated rats (P < 0.05; Fig. 5a).
Western blot analysis indicated that the NF-κB protein
level in Veh + CLP and CLP-12 h rats was much higher
than in both the sham-operated and PDTC + CLP
groups at respective time points (P < 0.05; Fig. 5b). There
were no significant differences in NF-κB protein level
between sham-operated rats at the time points of 3, 6,12 h 24 h 48 h
.07* 65.2 ± 3.96* 63.4 ± 3.65* 88.4 ± 5.13*
0.33* 390.2 ± 14.08* 404.2 ± 12.56* 364.4 ± 21.63*
Table 2 Vital signs at 12 h after operation for each group (n = 5)








317.2 ± 10.08 394.8 ± 7.46* 390.2 ± 14.08* 361.4 ± 10.69*,**
Values are expressed as means ± SEM
*P < 0.05 vs sham-operated group; **P < 0.05 vs 12 h or Veh + CLP group
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operated and CLP-12 h rats.Effects of PDTC on hippocampal tissue histology
Compared with sham-operated and CLP-12 h rats, as
described as before (Fig. 1a, c), the pathological changes
in the hippocampus of PDTC-treated rats were attenu-
ated (Fig. 6c).Effects of PDTC on LC-3, Beclin1, Rab7, and LAMP-1
expression in hippocampal tissue
The effects of PDTC on LC-3, Beclin1, Rab7, and
LAMP-1 protein levels were examined. Hippocampal tis-
sues were harvested from rats 12 h after CLP. As shown
in Fig. 7a, LC3-II grew in CLP rats receiving vehicle or
PDTC compared with sham-operated rats (P < 0.05). Ad-
ministration of PDTC after CLP showed a further
increase in LC3-II compared with vehicle-treated rats
(P < 0.05). Figure 7b, c, and d demonstrated that Beclin1,
Rab7, and LAMP-1 fell in CLP rats receiving vehicle or
PDTC compared with sham-operated rats (P < 0.05).
Administration of PDTC after CLP showed an increase
in Beclin1, Rab7, and LAMP-1 compared with vehicle-
treated rats (P < 0.05). There were no significant differ-
ences in LC-3, Beclin1, Rab7, and LAMP-1 protein levels
between vehicle-treated and CLP-12 h rats.Fig. 1 Pathological changes of hippocampus detected in each group. a In
normal. b In the CLP-3 h group, hippocampal cells showed slight edema. c
the structure was unclear; and neurons appeared to have experienced acu
and punctureLC3 expression was increased in the hippocampal tissue
after CLP surgery and PDTC treatment by fluorescence
microscopy
The effect of PDTC on LC3 in the brain was also evalu-
ated by fluorescence microscopy. In fluorescence micros-
copy experiments, autophagosomes were assessed by
examining the punctate form and distribution of LC3. As
shown in Fig. 8, compared with rats in sham-operated,
CLP-12 h, or Veh + CLP group, the PDTC+CLP rats
showed an elevated autophagy—the staining pattern
changes of LC3 from largely diffuse to predominantly
punctate and cytoplasmic, which was consistent with the
effects of PDTC on LC3 protein level observed by
Western blot on a section from the hippocampus.
Discussion
In our research, few changes in hippocampus vital signs
or morphology were observed at any time in samples ob-
tained from the sham-operated rats. In contrast, the
CLP rats showed decreasing MAP, increasing HR, and
pathological histological changes. In the PDTC + CLP
group, the damage to vital signs and morphology was at-
tenuated compared to the CLP group.
Autophagy is the process during which cells recycle
their own redundant, nonessential or damaged organ-
elles, and macromolecular components. The dynamic
process involves the complete flow of autophagy from
autophagosome formation to fusion with lysosome (“au-
tophagy flux”). The desire to investigate this process has
driven the development of improved approaches to de-
tecting autophagy. LC3 is widely used to monitor autop-
hagosomal formation or an indication of the number of
autophagosomes. The increased numbers of autophago-
somes do not always correlate with improved autophagic
activity, as the accumulation of autophagosomes may be
the result of the blocked autophagosome-lysosome fu-
sion. Except for LC-3, Beclin1, Rab7, and LAMP-1 havethe sham-operated group, hippocampal neurons appeared almost
In the CLP-12 h group, hippocampal cells were arranged in disorder;
te traumatic change. Original magnification: ×400. CLP cecal ligation
Fig. 2 Electron micrographs of the hippocampus detected at 12 h following sham operation (a), CLP-12 h (b), and CLP + PDTC-12 h (c). a Sham-operated
control rats showed organelles almost without pathological changes; no alteration of tissue integrity could be observed in low magnification images.
Magnification: ×10,000. b A large autophagosome contains mitochondria and other organelles; endoplasmic reticulum matrix into adjacent lysosomal
structures (arrow). Magnification: ×15,000. c CLP + PDTC-12 h displaying multiple double or multiple-membrane autophagic vesicles (arrows) in the
cytoplasm, with loss of discernable organellar fragments; autophagosomes assume a more complex appearance, with redundant whorls of
membrane-derived material. Magnification: ×10,000. CLP cecal ligation and puncture, PDTC pyrrolidine dithiocarbamate
Fig. 3 a LC3 in brains harvested 3, 6, 12, 24, and 48 h after CLP. b Immunofluorescence for LC3 in neurons after CLP injury. Values of protein data
were related to signals obtained from actin protein and given as relative arbitrary units. LC3-II significantly increased in CLP rats at 6, 12, 24, and
48 h after surgery compared with sham-operated rats. Three-color staining for anti-LC3 antibody (green), NeuN (red), and DAPI (blue) showed that
a staining pattern changes from largely diffuse to predominantly punctate and cytoplasmic in hippocampal neurons after CLP. Data were expressed as
mean ± SEM, n = 6/group. *P < 0.05 vs sham-operated group. LC-3 microtubule-associated protein light chain-3, CLP cecal ligation and puncture,
DAPI 4,6-diamidino-2-phenylindole
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Fig. 4 Beclin1 (a), LAMP-1 (b), and Rab7 (c) in brains harvested 3, 6, 12, 24, and 48 h after CLP. Protein data values were normalized to actin level
and given in relative arbitrary units. Compared with sham-operated group, Beclin1 level rose notably at 6 h but fell from 12 h; LAMP-1 levels
decreased at 3, 6, 12, 24, and 48 h after CLP. Rab7 dropped at 12, 24, and 48 h after CLP compared with those in sham-operated rats. Data were
expressed as mean ± SEM, n = 6/group. *P < 0.05 vs sham-operated group. CLP cecal ligation and puncture
Fig. 5 a NF-κB level in brains harvested 3, 6, 12, 24, and 48 h after CLP. b Effects of PDTC on NF-κB level in brains harvested 12 h after CLP. Protein data
values were normalized to actin level and reported in relative arbitrary units. NF-κB significantly increased at 12 and 24 h after CLP compared with that
in sham-operated rats. The expression of NF-κB protein decreased in the hippocampus after PDTC injection. Data were expressed as mean ± SEM,
n = 6/group. *P < 0.05 vs sham-operated group. #P < 0.05 vs 12 h or Veh + CLP group. NF-κB nuclear factor κB, CLP cecal ligation and puncture,
PDTC pyrrolidine dithiocarbamate
Su et al. Journal of Neuroinflammation  (2015) 12:116 Page 7 of 12
Fig. 6 Pathological changes in hippocampal tissue detected in each group. a In the sham-operated group, hippocampal neurons were almost
normal. b In the CLP-12 h group, hippocampal cells were disordered, the ultrastructure was not clear, and neurons appeared to have experienced
acute traumatic change. c In the PDTC-treated-12 h group, the pathological change was attenuated compared with the CLP-12 h group (original
magnification: ×400). CLP cecal ligation and puncture
Fig. 7 Effects of PDTC on LC3 (a), Beclin1 (b), LAMP-1 (c), and Rab7 (d) on the hippocampus of rats harvested 12 h after CLP. Values of protein
data are normalized to actin level and given in relative arbitrary units. LC3-II increased while Beclin1, Rab7, and LAMP-1 declined in CLP rats receiving
vehicle or PDTC compared with those in sham-operated rats. PDTC + CLP rats showed an increase in LC3-II, Beclin1, Rab7, and LAMP-1 compared with
vehicle-treated rats. Data were expressed as mean ± SEM, n = 6/group. *P < 0.05 vs sham-operated group. #P < 0.05 vs 12 h or Veh + CLP group. PDTC
pyrrolidine dithiocarbamate, LC-3 microtubule-associated protein light chain-3, CLP cecal ligation and puncture
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Fig. 8 a LC3 immunohistochemistry in neurons after CLP injury and PDTC treatment. Three-color staining for LC3 (green), NeuN (red), and DAPI
(blue) demonstrated an increase in LC3 punctate labeling in hippocampal neurons after CLP and PDTC treatment. The immunoreactivity of LC3
was elevated robustly in PDTC + CLP group. b Quantitative immunofluorescence data showed that the number of recognized cytoplasm intense
punctate LC3 cells is significantly increased in hippocampal neurons after PDTC treatment. Ten fields for each animal were randomly selected.
Data were expressed as mean ± SEM from five independent experiments in each group. n = 5/group. *P < 0.05 vs sham-operated group. #P < 0.05
vs 12 h or Veh + CLP group. Brain sections were viewed under a fluorescence microscope. Insets 400 μm. LC-3 microtubule-associated protein
light chain-3, CLP cecal ligation and puncture, PDTC pyrrolidine dithiocarbamate, DAPI 4,6-diamidino-2-phenylindole
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process. That is, Beclin1 facilitates autophagosome-
lysosomal fusion; Rab7 the late autophagosome matur-
ation; LAMP-1 the autophagosome-lysosome fusion.
That is why the mentioned four were monitored in our
research [26–30]. However, the role autophagy plays in
septic hippocampal damage has never been explored
before.
The presence of autophagy has been described in the
myocardium, liver, lung, and kidney afflicted by sepsis. Im-
paired autophagosome-lysosome fusion resulting in stalling
of the autophagy process may contribute to sepsis-induced
cardiac, lung, and liver injury [11, 31–33]. Treatment withpharmacological agents that enhance or impair autophagy
enables us to investigate the protective role of organelle
function in sepsis.
Our study demonstrates for the first time that
autophagy is induced in the hippocampus during CLP-
induced sepsis. The induction of autophagy was exam-
ined by a transmission electron microscopy, which
revealed that autophagy vacuoles contained cytoplasmic
organelles. The experiments also found the incomplete
activation of autophagy in hippocampus with sepsis by
two independent methods: immunoblot and immuno-
fluorescence. Representative Western blot and corre-
sponding densitometry showed that the formation of
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autophagosomes decreased in the hippocampus at 12 h
after CLP. Compared with sham-operated rats, CLP
rats exhibited higher LC3-II levels, more immunofluor-
escence, and a more pronounced punctate staining pat-
tern for LC3. Moreover, CLP rats were found to have a
decrease in Beclin1, Rab7, and LAMP-1, with the
exception of an increase in Beclin1 at 6 h after CLP. At
longer time periods after CLP in our research we
observed a phenomenon: the vital signs of CLP rats
improved along with the increase of Rab7 and LAMP-
1. This phenomenon is consistent with Lo et al.’s [32]
discovery. Lo et al. reported that appropriate autophagy
may protect against lung dysfunction in septic mice,
while excessive autophagosomes may lead to acute lung
injury through a supposed maladaptive role in the late
stage of sepsis, who also indicated that the over-
expression of LC3 attenuated lung injury via increasing
autophagosome-lysosome fusion by raising autophago-
some clearance. Though the mechanism of Rab7 and
LAMP-1 increase is unclear, it could be proposed that
acute hippocampal cell injury in return induces autoph-
agy [31–33].
The mechanisms underlying autophagosome forma-
tion and degradation have been extensively studied and
described in detail. However, the mechanism through
which autophagy contributes to so many important phe-
nomena of pathophysiology is largely unknown.
When sepsis occurs, the body produces large amounts
of cytokines. Significant blood–brain barrier damage and
brain dysfunction have appeared in the early stages of
septic hippocampal dysfunction, which were mainly
caused by systemic and cerebral inflammatory media-
tors. These mediators can induce inflammatory cells and
factors into the brain. In addition, since the integrity of
the endothelial cells in sepsis have been destroyed, com-
plement molecules, pro-inflammatory cytokines, and
other innate immune components can invade deep into
the brain and even bypass the blood–brain barrier through
special channels. All these stimuli would be the factors
inducing NF-κB activation [34–36]. Once it is activated, it
plays a pivot role in inflammatory, immune, anti-
apoptosis, and proliferation. It is the most important sig-
naling pathway activated in response to cell damage and
environmental danger [37].
Djavaheri-Mergny et al. [38] first reported that NF-
κB activation represses TNF-α-induced autophagy by
providing the evidence that TNF-α up-regulates mTOR
(mammalian target of rapamycin) activity in an NF-κB-
dependent manner but down-regulates in TNF-α-
treated cells lacking NF-κB activity. Furthermore,
autophagy has been demonstrated negatively regulated
by the mTOR pathway. However, in subsequent studies,
they and other scientists observed that NF-κB activitycan be modulated by autophagy-related signaling [39,
40]. Autophagy following defected Hsp90 function was
found to be able to degrade the IκB kinase (IKK), which
is an upstream activator of NF-κB. Recent studies have
demonstrated that autophagy is required for the activa-
tion of NF-κB and that TNF-α stimulates the lipidation
of LC3 [22].
Previous studies have shown that NF-κB activation
contributes to the pathogenesis of septic brain dysfunc-
tion. Siami et al. [41] determined that endothelial cell
activation results in the activation of the NF-κB signal
axis and the expression of TNF-α, interleukin-1β, and
interleukin-1 in the brain. In contrast to previous studies
[22], we found that the repression of NF-κB-stimulated
lipidation of LC3 accompanies autophagy.
To analyze the role of the NF-κB signaling pathway
in autophagy of the septic brain, PDTC, one water
soluble, low-molecular weight substance that inhibits
NF-κB-activation, was used as pretreatment before
CLP-induced sepsis [25]. PDTC treatment resulted in
an augmentation of autophagy at 12 h after CLP. As
shown by immunoblot and immunofluorescence, PDTC
treatment significantly promoted the shift of LC3-II
into LC3-I and increased the levels of Beclin1, Rab7,
and LAMP-1 compared to controls. The increased ex-
pression demonstrated in the PDTC + CLP group dem-
onstrated that the administration of PDTC might help
to restore incomplete autophagy, which was supported
by the work of Yuan-Chao Ye et al. [42], who indicated
that the inhibition of NF-κB increased TNF-α-induced
autophagy. Schlottmann et al. [23] observed a similar
phenomenon that the NF-κB signaling pathway could
inhibit autophagy in macrophages by down-regulating
Beclin1 expression and lead to apoptosis and resolution
of inflammation. In addition, we found that patho-
logical changes in the hippocampus of PDTC + CLP
group rats were attenuated in comparison with the
CLP-12 h rats. A possible explanation might be that
complete autophagy may perform a protective role in
the pathogenesis of septic hippocampal injury [42].
However, the observational nature of this study pre-
cludes us from determining the role autophagy plays in
the pathophysiology of hippocampal dysfunction with
sepsis. Since autophagy can be involved in either cell
death or survival based on the cellular context, it needs
further experiments to confirm whether the observed
autophagy is a pathologic mechanism that ultimately re-
sults in hippocampus damage or an adaptive mechanism
that is activated by septic stress. The use of pharmaco-
logical agents that can induce or inhibit autophagy may
allow investigators to figure out the beneficial or adverse
effects of autophagy on brains with sepsis. In this way,
the links between autophagy and sepsis will be revealed
in our future work.
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In summary, the above findings suggest that the incom-
plete activation of autophagy may contribute to hippocam-
pal dysfunction during sepsis. Treatment with PDTC
might serve a cerebral protective role in sepsis, possibly by
restoring the process of autophagy. Nonetheless, further
research is required to fully elucidate the role of autophagy
and the NF-κB signaling pathway in the septic brain. As
the first to elaborate the correlation between septic hippo-
campal dysfunction and autophagy, this study could pro-
vide novel therapeutic strategies for severe brain disease
with sepsis.
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